Platinum nanoparticles (PtNPs)-based CRISPR/Cas12a platform for detection of nucleic acid and protein in clinical samples
Jiajie Liang(Jinan University), Yong Tang(Southern Illinois University School of Medicine), Liangshan Hu(Guangdong Provincial People's Hospital), Guanbo He, Ying Zhang(Jinan University), Peijun Teng(Jinan University), Wei Xiao(Guangdong Provincial People's Hospital), Qifang Song(Jinan University), Gan Li(Jinan University), Bin Peng(Chinese Academy of Medical Sciences & Peking Union Medical College), Donglin Cao(Guangdong Provincial People's Hospital)
Cited by 16
Related Papers
In silico screening of Chinese herbal medicines with the potential to directly inhibit 2019 novel coronavirus
|Journal of Integrative Medicine|2020|491
Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death
|Cell Death and Differentiation|2010|199
Role of Alcohol Drinking in Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
|International Journal of Molecular Sciences|2020|153
Expressions of Nuclear Factor κB, Inducible Nitric Oxide Synthase, and Vascular Endothelial Growth Factor in Adenoid Cystic Carcinoma of Salivary Glands: Correlations with the Angiogenesis and Clinical Outcome
|Clinical Cancer Research|2005|134
Application of the amplification-free SERS-based CRISPR/Cas12a platform in the identification of SARS-CoV-2 from clinical samples
|Journal of Nanobiotechnology|2021|82